Horizon Therapeutics Public Limited Company
USD116.30
+0.00 (+0.00%)
CEO
Timothy P. Walbert
IPO Date
2011-07-28
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
Country
IE
Open
$116.34
Prev. Close
$116.30
Day Low
$116.30
Day High
$116.34
52W Low
$116.30
52W High
$116.34
Market Cap
$26.60B
Volume
23.92M
| 45.5 |
| 31 Dec 2020 | FY | 75.8% | 17.7% | 9.7% | 6.4% | 0.25 | 3.51 | 40.4 |
| 31 Dec 2019 | FY | 72.1% | 44.1% | 26.2% | 12.9% | 0.62 | 2.33 | 13.0 |
| 31 Dec 2018 | FY | 65.0% | -6.1% | -7.0% | -1.8% | 1.80 | 2.03 | -43.8 |
| 31 Dec 2017 | FY | 48.3% | -38.9% | -41.4% | -9.9% | 1.92 | 1.63 | -5.8 |
| 31 Dec 2016 | FY | 59.9% | -17.0% | -13.2% | -3.9% | 1.43 | 1.73 | -15.6 |
| 31 Dec 2015 | FY | 71.0% | 5.2% | 3.0% | 1.3% | 0.87 | 3.09 | 81.6 |
| 31 Dec 2014 | FY | 73.5% | -88.8% | -48.8% | -23.2% | 0.64 | 1.49 | -4.1 |
| 31 Dec 2013 | FY | 80.2% | -201.3% | 303.6% | -59.0% | -2.26 | 2.56 | -3.3 |
| 114.0 |
| 31 Dec 2022 | Q4 | 74.4% | 12.8% | 2.4% | 1.3% | 0.51 | 3.85 | 53.6 |
| 30 Sept 2022 | Q3 | 74.7% | 14.7% | 2.7% | 1.5% | 0.51 | 3.96 | 26.2 |
| 30 Jun 2022 | Q2 | 73.7% | 7.0% | 1.2% | 0.7% | 0.52 | 4.05 | 75.2 |
| 31 Mar 2022 | Q1 | 75.7% | 23.1% | 4.2% | 2.3% | 0.53 | 3.57 | 29.5 |
| 31 Dec 2021 | Q4 | 76.2% | 17.1% | 3.7% | 2.0% | 0.55 | 3.16 | 35.3 |
| 30 Sept 2021 | Q3 | 75.7% | 31.5% | 7.3% | 3.8% | 0.58 | 2.83 | 19.0 |
| 30 Jun 2021 | Q2 | 75.9% | 19.0% | 3.9% | 1.9% | 0.63 | 2.55 | 33.3 |
| 31 Mar 2021 | Q1 | 70.7% | -36.0% | -3.2% | -1.6% | 0.67 | 2.37 | -41.8 |